Ross Dixon

1.6k total citations
50 papers, 1.3k citations indexed

About

Ross Dixon is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ross Dixon has authored 50 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ross Dixon's work include Drug Transport and Resistance Mechanisms (10 papers), Analytical Chemistry and Chromatography (8 papers) and Hormonal and reproductive studies (5 papers). Ross Dixon is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Analytical Chemistry and Chromatography (8 papers) and Hormonal and reproductive studies (5 papers). Ross Dixon collaborates with scholars based in United States, Switzerland and Canada. Ross Dixon's co-authors include Louis Shuster, Nicholas H. Dodman, Michael H. Court, Jane Hsiao, Edmund J. Moran, Sonja Krane, Michael Newman, Khalid Benbatoul, James M. Fujitaki and Chengzhi Zhang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Methods in enzymology on CD-ROM/Methods in enzymology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Ross Dixon

47 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ross Dixon United States 21 390 263 174 133 132 50 1.3k
R. R. Brown United States 32 970 2.5× 240 0.9× 132 0.8× 75 0.6× 136 1.0× 100 3.3k
Hiromasa Okada Japan 16 437 1.1× 575 2.2× 109 0.6× 84 0.6× 83 0.6× 45 1.4k
Norbert Kolassa Germany 20 629 1.6× 123 0.5× 220 1.3× 53 0.4× 175 1.3× 54 1.3k
Naoko Tanaka Japan 29 1.1k 2.9× 229 0.9× 106 0.6× 104 0.8× 62 0.5× 145 2.6k
Daniel Morton United States 25 920 2.4× 165 0.6× 244 1.4× 91 0.7× 93 0.7× 93 2.4k
Andrea Carmine Sweden 24 611 1.6× 121 0.5× 548 3.1× 173 1.3× 98 0.7× 26 2.4k
Samson Symchowicz United States 22 268 0.7× 114 0.4× 124 0.7× 35 0.3× 115 0.9× 58 1.2k
John P. Long United States 24 592 1.5× 123 0.5× 372 2.1× 374 2.8× 59 0.4× 115 1.7k
R. De Coster Belgium 29 713 1.8× 451 1.7× 129 0.7× 68 0.5× 138 1.0× 70 2.7k
Fiorenzo Mignini Italy 23 461 1.2× 107 0.4× 197 1.1× 63 0.5× 55 0.4× 80 1.5k

Countries citing papers authored by Ross Dixon

Since Specialization
Citations

This map shows the geographic impact of Ross Dixon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Dixon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Dixon more than expected).

Fields of papers citing papers by Ross Dixon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross Dixon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Dixon. The network helps show where Ross Dixon may publish in the future.

Co-authorship network of co-authors of Ross Dixon

This figure shows the co-authorship network connecting the top 25 collaborators of Ross Dixon. A scholar is included among the top collaborators of Ross Dixon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross Dixon. Ross Dixon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leggat, William, et al.. (2005). A novel carbonic anhydrase from the giant clam Tridacna gigas contains two carbonic anhydrase domains. FEBS Journal. 272(13). 3297–3305. 21 indexed citations
2.
N., Kim, Stephen Chia, Ross Dixon, et al.. (2005). A phase I pharmacokinetic study of the P-glycoprotein inhibitor, ONT-093, in combination with paclitaxel in patients with advanced cancer. Investigational New Drugs. 23(4). 311–315. 37 indexed citations
3.
Guns, Emma S. Tomlinson, et al.. (2001). Assessment of the involvement of CYP3A in the vitro metabolism of a new modulator of MDR in cancer chemotherapy, OC144-193, by human liver microsomes. European Journal of Drug Metabolism and Pharmacokinetics. 26(4). 273–282. 10 indexed citations
4.
Zhang, Chengzhi, Sepehr Sarshar, Edmund J. Moran, et al.. (2001). ChemInform Abstract: 2,4,5‐Trisubstituted Imidazoles: Novel Nontoxic Modulators of P‐Glycoprotein Mediated Multidrug Resistance. Part 2.. ChemInform. 32(14). 3 indexed citations
5.
Zhang, Chengzhi, Sepehr Sarshar, Edmund J. Moran, et al.. (2000). 2,4,5-Trisubstituted imidazoles. Bioorganic & Medicinal Chemistry Letters. 10(23). 2603–2605. 53 indexed citations
6.
Sarshar, Sepehr, Chengzhi Zhang, Edmund J. Moran, et al.. (2000). 2,4,5-Trisubstituted imidazoles. Bioorganic & Medicinal Chemistry Letters. 10(23). 2599–2601. 37 indexed citations
8.
Fujitaki, James M., et al.. (1994). Spectrophotometric determination of acadesine (AICA-riboside) in plasma using a diazotization coupling technique with N-(1-naphthyl)ethylenediamine. Journal of Biochemical and Biophysical Methods. 29(2). 143–148. 4 indexed citations
9.
Dixon, Ross, et al.. (1993). Acadesine (AICA‐Riboside): Disposition and Metabolism of an Adenosine‐Regulating Agent. The Journal of Clinical Pharmacology. 33(10). 955–958. 17 indexed citations
10.
Knupp, C A, Francesco Graziano, Ross Dixon, & Rashmi H. Barbhaiya. (1992). Pharmacokinetic-interaction study of didanosine and ranitidine in patients seropositive for human immunodeficiency virus. Antimicrobial Agents and Chemotherapy. 36(10). 2075–2079. 20 indexed citations
11.
Dixon, Ross, et al.. (1991). AICA‐Riboside: Safety, Tolerance, and Pharmacokinetics of a Novel Adenosine‐Regulating Agent. The Journal of Clinical Pharmacology. 31(4). 342–347. 93 indexed citations
12.
Sanderson, John E., et al.. (1989). Iontophoretic Delivery of Nonpeptide Drugs: Formulation Optimization for Maximum Skin Permeability. Journal of Pharmaceutical Sciences. 78(5). 361–364. 30 indexed citations
13.
Dixon, Ross, et al.. (1989). Isolation of a Novel Morphinan 3-O-Diglucuronide Metabolite from Dog Urine. Pharmaceutical Research. 6(1). 28–32. 11 indexed citations
14.
Dodman, Nicholas H., et al.. (1988). Use of narcotic antagonists to modify stereotypic self-licking, self-chewing, and scratching behavior in dogs. Journal of the American Veterinary Medical Association. 193(7). 815–819. 50 indexed citations
15.
Dodman, Nicholas H., Louis Shuster, Michael H. Court, & Ross Dixon. (1987). Investigation into the use of narcotic antagonists in the treatment of a stereotypic behavior pattern (crib-biting) in the horse. American Journal of Veterinary Research. 48(2). 311–319. 83 indexed citations
16.
Dixon, Ross, et al.. (1987). Nalmefene: Safety and Kinetics After Single and Multiple Oral Doses of a New Opioid Antagonist. The Journal of Clinical Pharmacology. 27(3). 233–239. 64 indexed citations
17.
Sanderson, John E., Robert W. Caldwell, Jane Hsiao, Ross Dixon, & Ronald R. Tuttle. (1987). Noninvasive Delivery of a Novel Inotropic Catecholamine: Iontophoretic versus Intravenous Infusion in Dogs. Journal of Pharmaceutical Sciences. 76(3). 215–218. 26 indexed citations
18.
Glover, William, et al.. (1980). Radioimmunoassay of flurazepam in human plasma. Journal of Pharmaceutical Sciences. 69(5). 601–602. 19 indexed citations
19.
Dixon, Ross, et al.. (1975). Disposition of the retro-steroid progestogen, 6-chloro-9β, 10α-pregna-1,4,6-triene-3,20-dione (Ro 4-8347), in man. Contraception. 11(3). 339–346. 1 indexed citations
20.
Kawashima, Koichiro, Ross Dixon, & Sydney Spector. (1975). Development of radioimmunoassay for chlorpromazine. European Journal of Pharmacology. 32(2). 195–202. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026